The trial in India is part of a multi-country initiative of the same vaccine candidate. Trials are already on in Germany and Belgium and initial results have given excellent safety data.
The increase in the numbers is reasoned to the absence of a regulatory or monitoring agency, official sources said.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.
The active cases comprise 1.03 per cent of the total infections while the national COVID-19 recovery rate was recorded at 97.63 per cent, the ministry said.
The doctors treating SARS suspects or patients will use the Defence Research Development Organisation made Nuclear-Biological-Chemical weapon masks.
India logged 36,571 new coronavirus infections, taking the total tally of Covid-19 cases to 3,23,58,829, while the national recovery rate improved to 97.54 per cent, the highest since March 2020, according to the Union health ministry data updated on Friday.
All COVID vaccines do not prevent infection and are primarily disease-modifying, said Dr Balram Bhargava, director general, Indian Council of Medical Research on Thursday.
The number of people who have recuperated from the disease has gone up to 4,24,85,534.
The ICMR's statement came against the backdrop of the World Health Organization (WHO) suspending the testing of the drug in COVID-19 patients temporarily in its global study following safety concerns.
The country recorded 311 new deaths in the 24-hour period till Sunday morning while the recovery rate rose to above 50 per cent
Anil Vij was administered the trial dose of the indigenous COVID vaccine Covaxin last month
India saw a single-day rise of 38,667 coronavirus infections, taking the total tally of cases to 3,21,56,493, while the death toll rose to 4,30,732 with 478 fresh fatalities, according to the Union health ministry data updated Saturday.
SP leader Akhilesh Yadav reacted quickly to the allegation, tweeting that the red caps are a 'red alert' for the Bharatiya Janata Party itself as they will oust that party from power.
A bench of Justices Hima Kohli and Subramonium Prasad observed that 'corona capital' was 'an epithet the city can well do without' and said it was need of the hour that all private hospitals equipped with labs to test for COVID-19 be permitted to do so without losing any more time.
The tally of active cases now comprises 0.05 per cent of the total infections.
The number of people who have recuperated from the disease surged to 3,10, 99,771, while the case fatality rate stands at 1.34 per cent.
The number of active cases remained below 5 lakh for the ninth consecutive day.
The minister said he was not supposed to say anything officially as he was still in touch with the union health ministry and the ICMR officials.
According to sources, so far only one traveller from Canada having symptoms of monkeypox infection had been isolated.
The active cases have declined to 4,24,025 and comprise 1.36 per cent of the total infections.
The number of active cases of the coronavirus infection in the country has gone up to 37,45,237, accounting for 16.53 per cent of its total caseload, while the national COVID-19 recovery rate was recorded at 82.39 per cent.
A total of 1,59,632 new coronavirus infections were reported in a day, the highest in 224 days.
September witnessed 24,33,319 people recuperating from coronavirus infection contributing to around 46.15 per cent of the total 52,73,201 recoveries registered so far in the country.
The active cases have further declined to 4,59,920 and comprise 1.50 per cent of the total infections, while the national COVID-19 recovery rate has improved to 97.18 per cent, the data updated at 8 am showed.
The 'antisera' has been developed by the ICMR in collaboration with a Hyderabad-based bio-pharmaceutical firm. "With Biological E Limited we have developed an horse 'antisera' and we have just got clearance for conducting clinical trials for that," ICMR Director General Dr Balram Bhargava said at press briefing.
The active cases have further declined to 4,85,350 and comprise 1.59 per cent of the total infections, while the national COVID-19 recovery rate has improved to 97.09 per cent, the ministry said.
"The unsound analysis of the said article is based on the extrapolation of data without any epidemiological evidence," the ministry said, adding the studies used by the magazine to estimate the mortality are not validated tools for determining the death rate of any country or region.
The Centre on Saturday night announced that the probe into alleged irregularities in the medical entrance exam NEET will be handed over to the CBI for a comprehensive investigation.
A single-day rise of 50,040 fresh COVID-19 infections took India's tally to 3,02,33,183, while the number of active cases dipped to 5,86,403, according to the Union health ministry data on Sunday.
India logged 44,877 infections, while the death toll climbed to 5,08,665 with 684 fresh fatalities, the data updated at 8 am stated.
"We are very worried about the rise in cases in Maharashtra. Don't take this virus for granted. It can come up unexpectedly. If we have to remain free of this virus, COVID-appropriate behaviour, containment strategy as well as vaccination has to be brought in," Paul said.
Findings of the Indian Council of Medical Research's fourth national Covid sero survey show there is a ray of hope, but there is no room for complacency and Covid-appropriate behaviour has to be followed, the government said.
The number of people who have recovered from the disease has risen to 3,02,69,796, while the case fatality rate has increased to 1.33 per cent, the data stated.
A third wave of COVID-19 -- if it occurs -- is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study.
The active cases comprise 3.42 per cent of the total infections.
rediffGURU Maxim Emmanuel offers expert advice on how to make an informed career choice.
India-born Nobel laureate Sir Venkatraman Ramakrishnan has been confirmed as president elect of Britain's prestigious Royal Society.
The total coronavirus cases mounted to 51,18,253, while the death toll climbed to 83,198 with the virus claiming 1,132 lives in a span of 24 hours, the data updated at 8 am showed.
With 8,439 more people testing positive for COVID-19 in a day, India's infection tally rose to 3,46,56,822 on Wednesday, while the count of active cases declined to 93,733, the lowest in 555 days, according to the Union Health Ministry data.
